OncoMultiDx Rapid Cancer Screen
|

OncoFirm Diagnostics Announces Launch and Opens First Round Funding Opportunities Up to $10 Million

Byadmin

FOR IMMEDIATE RELEASEContact: Jonathan Adam BarashEmail: press@oncofirmdiagnostics.comPhone: 516-900-2606Website: www.oncofirmdiagnostics.com OncoFirm Diagnostics Corp. Announces Launch and Opens First Round Funding Opportunities Up to $10 Million Revolutionizing Early Cancer Detection Through Rapid, Antigen-Based Screening Technology Port Washington, New York — April 7 — OncoFirm Diagnostics Corp., a cutting-edge medical diagnostics company, today announced its official launch and…

OnCofirm Rapid Cancer Tests

PR NEWSWIRE 2025

Byadmin

ONCOFIRM DIAGNOSTICS April 1 2025 Revolutionizing Cancer Detection ONCOFIRM DIAGNOSTICS is revolutionizing cancer detection with cutting-edge lateral flow assay (LFA) technology, integrating the latest advancements in nanoparticle conjugation, signal amplification, and multiplex detection for unmatched sensitivity and accuracy. Leveraging highly specific Thomsen-Friedenreich (TF) and Gal-GalNAc antigens, our rapid tests provide early, reliable, and accessible cancer…